Please assess the completion status of the following clinical trial:

Trial Title: A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Males or females who weigh at least 9 kg.~* Anticipated to be living or working in the same household as a patient in one of the fordadistrogene movaparvovec interventional studies for at least 4 months.~* Anticipated to have \> 10 hours of contact per week and expected to have direct contact with the interventional study patient.~* The interventional patient is dosed in the interventional study.~Exclusion Criteria:~* Prior treatment with gene therapy utilizing AAV vectors of any serotype.

- Gender: ALL
- Minimum Age: 0 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- All participants (Type: None): Household contacts of a DMD patient in an interventional study of fordadistrogene movaparvovec.

Based on this trial design, predict the completion outcome and termination type (if applicable).